tradingkey.logo
tradingkey.logo
Suchen

Translational Development Acquisition Corp

TDACU
Zur Watchlist hinzufügen
11.310USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
234.63MMarktkapitalisierung
--KGV TTM

Translational Development Acquisition Corp

11.310
0.0000.00%

mehr Informationen über Translational Development Acquisition Corp Unternehmen

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

Translational Development Acquisition Corp Informationen

BörsenkürzelTDACU
Name des UnternehmensTranslational Development Acquisition Corp
IPO-datumDec 23, 2024
CEOHoffman (Michael B)
Anzahl der mitarbeiter- -
WertpapierartUnit
Geschäftsjahresende- -
Addresse52 E 83Rd St.
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10028
Telefon14132042769
Website
BörsenkürzelTDACU
IPO-datumDec 23, 2024
CEOHoffman (Michael B)

Führungskräfte von Translational Development Acquisition Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Translational Development Acquisition Corp?

Die fünf größten Anteilseigner von Translational Development Acquisition Corp sind: Mr. Michael B. Hoffman

Wie viele Institutionen halten Anteile an Translational Development Acquisition Corp (TDACU)?

Mit Stand vom 2026Q1 halten 47 Institutionen Anteile an Translational Development Acquisition Corp, mit einem Gesamtmarktwert von etwa 958.07K, was 5.55% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -14147897.00 gestiegen.